[EFFECT] Tvardi Therapeutics, Inc. SEC Filing Filing Impact (Neutral) Filing Sentiment (Neutral) Form Type EFFECT 05/14/2026 - 12:15 AM ⛶ Fullscreen UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: May 13, 2026 Accession Number: 0001104659-26-057914 Submission Type: POS AM CIK: 0001346830 Company Name: Tvardi Therapeutics, Inc. File Number: 333-287675 Source: View Original Filing on SEC EDGAR
